US Patent

US12358870 — Solid dispersions and pharmaceutical compositions comprising a substituted indane and methods for the preparation and use thereof

Formulation · Assigned to Peloton Therapeutics Inc · Expires 2042-06-30 · 16y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects solid dispersions and pharmaceutical compositions containing a HIF-2α inhibitor for treating HIF-2α-mediated diseases and conditions.

USPTO Abstract

Provided herein are solid dispersions comprising a HIF-2Î± inhibitor, pharmaceutical compositions comprising the solid dispersions, and methods for treating HIF-2Î±-mediated diseases and conditions.

Drugs covered by this patent

Welireg (BELZUTIFAN) · Merck & Co.

Patent Metadata

Patent number: US12358870
Jurisdiction: US
Classification: Formulation
Expires: 2042-06-30
Drug substance claim: No
Drug product claim: Yes
Assignee: Peloton Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.